Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 May 1;181(5):1847-55.
doi: 10.1084/jem.181.5.1847.

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

Affiliations

Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association

J Hammer et al. J Exp Med. .

Abstract

We have investigated whether sequence 67 to 74 shared by beta chains of rheumatoid arthritis (RA)-associated HLA-DR molecules imparts a specific pattern of peptide binding. The peptide binding specificity of the RA-associated molecules, DRB1*0401, DRB1*0404, and the closely related, RA nonassociated DRB1*0402 was, therefore, determined using designer peptide libraries. The effect of single key residues was tested with site-directed mutants of DRB1*0401. The results have demonstrated striking differences between RA-linked and unlinked DR allotypes in selecting the portion of peptides that interacts with the 67-74 area. Most differences were associated with a single amino acid exchange at position 71 of the DR beta chain, and affected the charge of residues potentially contacting position 71. The observed binding patterns permitted an accurate prediction of natural protein derived peptide sequences that bind selectively to RA-associated DR molecules. Thus, the 67-74 region, in particular position 71, induces changes of binding specificity that correlate with the genetic linkage of RA susceptibility. These findings should facilitate the identification of autoantigenic peptides involved in the pathogenesis of RA.

PubMed Disclaimer

Comment in

References

    1. J Exp Med. 1977 Sep 1;146(3):857-68 - PubMed
    1. J Clin Invest. 1993 Sep;92(3):1387-93 - PubMed
    1. Arthritis Rheum. 1987 Mar;30(3):306-18 - PubMed
    1. Cell. 1987 Apr 24;49(2):273-80 - PubMed
    1. Arthritis Rheum. 1987 Nov;30(11):1205-13 - PubMed

Publication types